Posted by Michael Wonder on 16 Sep 2021
Moderna announces Health Canada approves its COVID-19 vaccine
16 September 2021 - Moderna today announced Health Canada has approved the new drug submission for Spikevax (elasomeran mRNA vaccine), which has been known as COVID-19 Vaccine Moderna, for active immunisation to prevent COVID-19 in individuals 12 years of age and older.
Health Canada approved the new drug submission for Spikevax based on clinical data from the Phase 3 COVE trial of the Moderna COVID-19 vaccine, which enrolled more than 30,000 participants in the U.S.
